Luís Borges

4.0k total citations · 1 hit paper
56 papers, 3.1k citations indexed

About

Luís Borges is a scholar working on Immunology, Molecular Biology and Civil and Structural Engineering. According to data from OpenAlex, Luís Borges has authored 56 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 12 papers in Molecular Biology and 12 papers in Civil and Structural Engineering. Recurrent topics in Luís Borges's work include Immune Cell Function and Interaction (20 papers), T-cell and B-cell Immunology (11 papers) and Structural Load-Bearing Analysis (10 papers). Luís Borges is often cited by papers focused on Immune Cell Function and Interaction (20 papers), T-cell and B-cell Immunology (11 papers) and Structural Load-Bearing Analysis (10 papers). Luís Borges collaborates with scholars based in United States, Portugal and Australia. Luís Borges's co-authors include David Cosman, Neil A. Fanger, Marek Kubin, Wilson Chin, Nicodemus Tedla, Alain Nussbaumer, Claire L. Sutherland, Lara Stepan, Guiomar Oliveira and Carla Marques and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Luís Borges

56 papers receiving 3.0k citations

Hit Papers

A Novel Immunoglobulin Superfamily Receptor for Cellular ... 1997 2026 2006 2016 1997 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luís Borges United States 28 1.8k 429 386 383 332 56 3.1k
Hyun Sil Kim South Korea 28 382 0.2× 2.6k 6.1× 156 0.4× 854 2.2× 62 0.2× 152 4.3k
Takahiro Suzuki Japan 25 246 0.1× 800 1.9× 160 0.4× 153 0.4× 83 0.3× 81 2.1k
Takao Ando Japan 30 232 0.1× 847 2.0× 393 1.0× 360 0.9× 42 0.1× 122 3.3k
Xiaoqi Wang China 21 222 0.1× 528 1.2× 60 0.2× 247 0.6× 28 0.1× 80 1.6k
Chunhe Wang China 17 614 0.3× 235 0.5× 120 0.3× 221 0.6× 26 0.1× 52 1.3k
Chenxi Zheng China 29 306 0.2× 1.2k 2.8× 78 0.2× 174 0.5× 9 0.0× 82 2.7k
Noriaki Yoshida Japan 31 240 0.1× 1.4k 3.4× 201 0.5× 489 1.3× 40 0.1× 131 2.9k
David A. Whiting United States 32 221 0.1× 467 1.1× 511 1.3× 78 0.2× 140 0.4× 77 3.9k
Yu‐Feng Su Taiwan 20 250 0.1× 218 0.5× 32 0.1× 74 0.2× 59 0.2× 96 1.4k
Hideaki Suda Japan 39 216 0.1× 567 1.3× 44 0.1× 70 0.2× 18 0.1× 230 4.5k

Countries citing papers authored by Luís Borges

Since Specialization
Citations

This map shows the geographic impact of Luís Borges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luís Borges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luís Borges more than expected).

Fields of papers citing papers by Luís Borges

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luís Borges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luís Borges. The network helps show where Luís Borges may publish in the future.

Co-authorship network of co-authors of Luís Borges

This figure shows the co-authorship network connecting the top 25 collaborators of Luís Borges. A scholar is included among the top collaborators of Luís Borges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luís Borges. Luís Borges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hall, Matthew S., et al.. (2023). Abstract 2914: iPSC-derived CAR-NK cell therapy: nominating clinical candidate clones through integrated multi-functional analysis. Cancer Research. 83(7_Supplement). 2914–2914. 1 indexed citations
2.
Hsu, Amy, Hong Xiang, Ago Ahene, et al.. (2017). FPA150, a novel B7-H4 therapeutic antibody with checkpoint blockade and ADCC activities. Annals of Oncology. 28. v2–v2. 2 indexed citations
3.
Lu, Hao, Yasumi Endoh, Taline Hampartzoumian, et al.. (2012). LILRA2 Selectively Modulates LPS-Mediated Cytokine Production and Inhibits Phagocytosis by Monocytes. PLoS ONE. 7(3). e33478–e33478. 27 indexed citations
4.
Tedla, Nicodemus, Luís Borges, Uté Vollmer‐Conna, et al.. (2011). Expression of activating and inhibitory leukocyte immunoglobulin‐like receptors in rheumatoid synovium: correlations to disease activity. Tissue Antigens. 77(4). 305–316. 16 indexed citations
5.
6.
Temudo, Teresa, Elisabete Ramos, Karin Ziliotto Dias, et al.. (2008). Movement disorders in Rett syndrome: An analysis of 60 patients with detected MECP2 mutation and correlation with mutation type. Movement Disorders. 23(10). 1384–1390. 66 indexed citations
7.
Rentero, Carles, Yasumi Endoh, Kenneth Hsu, et al.. (2008). LILRA5 is expressed by synovial tissue macrophages in rheumatoid arthritis, selectively induces pro‐inflammatory cytokines and IL‐10 and is regulated by TNF‐α, IL‐10 and IFN‐γ. European Journal of Immunology. 38(12). 3459–3473. 37 indexed citations
8.
Oliveira, Guiomar, Jinong Feng, Yan Jin, et al.. (2007). MECP2 coding sequence and 3′UTR variation in 172 unrelated autistic patients. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 144B(4). 475–483. 46 indexed citations
9.
Hampartzoumian, Taline, John A. Hunt, Luís Borges, et al.. (2007). Down-regulation of leucocyte immunoglobulin-like receptor expression in the synovium of rheumatoid arthritis patients after treatment with disease-modifying anti-rheumatic drugs. Lara D. Veeken. 46(5). 742–751. 34 indexed citations
10.
Wei, Ping, Jinghui Zhan, Shuying Liu, et al.. (2006). Generation and Characterization of Monoclonal Antibodies to Human Keratinocyte Growth Factor Receptor. Hybridoma. 25(3). 115–124. 3 indexed citations
11.
Borges, Luís, Karen Rex, Ping Wei, et al.. (2006). A protective role for keratinocyte growth factor in a murine model of chemotherapy and radiotherapy-induced mucositis. International Journal of Radiation Oncology*Biology*Physics. 66(1). 254–262. 23 indexed citations
12.
Correia, Catarina, Luísa Diogo, Manuela Grazina, et al.. (2006). Brief Report: High Frequency of Biochemical Markers for Mitochondrial Dysfunction in Autism: No Association with the Mitochondrial Aspartate/Glutamate Carrier SLC25A12 Gene. Journal of Autism and Developmental Disorders. 36(8). 1137–1140. 88 indexed citations
13.
Correia, Catarina, Constantin Fesel, Marta Barreto, et al.. (2004). Autoantibody repertoires to brain tissue in autism nuclear families. Journal of Neuroimmunology. 152(1-2). 176–182. 61 indexed citations
14.
Tedla, Nicodemus, Kathryn Gibson, H. Patrick McNeil, et al.. (2002). The Co-Expression of Activating and Inhibitory Leukocyte Immunoglobulin-Like Receptors in Rheumatoid Synovium. American Journal Of Pathology. 160(2). 425–431. 36 indexed citations
15.
Borges, Luís & David Cosman. (2000). LIRs/ILTs/MIRs, inhibitory and stimulatory Ig-superfamily receptors expressed in myeloid and lymphoid cells. Cytokine & Growth Factor Reviews. 11(3). 209–217. 102 indexed citations
16.
Borges, Luís, Robert E. Miller, Jon Jones, et al.. (1999). Synergistic Action of fms-Like Tyrosine Kinase 3 Ligand and CD40 Ligand in the Induction of Dendritic Cells and Generation of Antitumor Immunity In Vivo. The Journal of Immunology. 163(3). 1289–1297. 44 indexed citations
17.
Kubin, Marek, Wenie S. Din, Terri Davis‐Smith, et al.. (1999). Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD48. European Journal of Immunology. 29(11). 3466–3477. 74 indexed citations
18.
Fanger, Neil A., et al.. (1998). The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes. European Journal of Immunology. 28(11). 3423–3434. 165 indexed citations
19.
Cosman, David, et al.. (1997). A Novel Immunoglobulin Superfamily Receptor for Cellular and Viral MHC Class I Molecules. Immunity. 7(2). 273–282. 570 indexed citations breakdown →
20.
Borges, Luís, et al.. (1997). A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. The Journal of Immunology. 159(11). 5192–5196. 292 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026